24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:54
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
11:21
Mixpanel is here to help gaming companies democratize their data
09:10
Here’s how gaming brands can reach wider audiences: “Never make assumptions!”
09:01
Israel’s gaming sector is 2% of its GDP - so why is the government ignoring it?
More stories
Buzz
Most popular
Daily
Weekly
1
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
2
TechAir flights from Israel to New York take off January 21
3
Defense tech is booming—but who will actually win?
4
Windward acquired for $270M by FTV Capital, doubling its IPO valuation
5
$41B in exits: Why Israeli cyber startups are a global powerhouse
More news
Medical
20 stories about Medical
Flu Season Might Soon Pass, for Good
11.12.19
|
Lilach Baumer
The researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial
Former Israeli Representative to UN Hops on Cannabis Wagon
24.11.19
|
Tzally Greenberg
Dan Gillerman will step in as the chairman of Israel-based medical cannabis company Pharmocann
Together Banks on Health Ministry Exemptions to Import its Ugandan Cannabis to Israel
21.11.19
|
Tzally Greenberg
The Israeli market has been experiencing severe shortages in medical cannabis in the past few months following a recent regulatory reform spearheaded by the health ministry
Teva’s Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing
17.11.19
|
Navit Zomer
The Israeli drugmaker’s manufacturing facility in Kfar Saba, already experienced with manufacturing cash cow Copaxone, will oversee the process of filling the syringes with the biological drug and also conduct quality control tests
Canada’s Cannabis Engine Struggles to Climb Up Regulation Hill
14.11.19
|
Tzally Greenberg
After launching with much fanfare, the Canadian cannabis industry has found itself crumbling under mounting debt as a result of much red tape. The industry is also thirsty for skilled workers, with a recently opened college program attempting to meet that need
Canada’s Cronos Starts Growing First Cannabis Seedlings on Israeli Soil
13.11.19
|
Tzally Greenberg
The Nasdaq and Toronto-listed cannabinoid company signed a partnership with northern Israeli Kibbutz Gan Shmuel in 2017
Israel Excels in Health, No Thanks to Government Spending, Report Says
10.11.19
|
Adrian Filut
The OECD’s most recent health report finds that Israel’s health expenditure is some of the lowest among the countries surveyed
AXA-Backed Kamet Taps Israeli Health Ministry Exec for Insurtech Incubator
31.10.19
|
Sophie Shulman
Until recently, Ravit Warsha Dor served as head of innovation at the Israeli health ministry's digital health department
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch
29.10.19
|
Sophie Shulman
The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.
Cannabis Company Better Holdings Wants to Sell Israeli Operations
29.10.19
|
Tzally Greenberg
Better used to be the second largest medical cannabis company in Israel with 5,000 patients, but Israel's recent cannabis reform piled trouble on the company, which had yet to be reissued its permanent license under the new, more stringent regulations
Israel’s Medical Cannabis Reform Continues to Benefit Nearly No One
20.10.19
|
Tzally Greenberg
Coming into full effect in September and intended to help standardize the industry, the reform has so far resulted in market shortages and hiked prices
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says
16.10.19
|
Hezi Sternlicht
The Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court
Herodium and Cannabis Company Panaxia Complete Merger
02.10.19
|
Tzally Greenberg
The merger, first reported in the beginning of the year, was made possible by a $4.25 million investment round in September
Baring Private Equity Asia Nearing Acquisition of Medical Laser Company Lumenis, Report Says
26.09.19
|
CTech
Earlier this week, Bloomberg reported that the private equity firm is in exclusive talks with Lumenis’ owner XIO Group
Cannbit Wins Race for Tikun Olam's Israeli Business
16.09.19
|
Tzally Greenberg
The acquisition will give Cannbit control of the entire medical cannabis supply chain
Alibaba-Operated Tmall Looking for Israeli Brands
15.09.19
|
Meir Orbach
Liu Ying, who heads Tmall’s premium beauty business, told Calcalist the company is looking for Israeli suppliers in the domains of beauty and aesthetics
Medical Cannabis Company Together Plans to List Subsidiary Cannabliss in North America
15.09.19
|
Tzally Greenberg
Cannabliss develops and manufactures smoke-free cannabis products, such as oils, candies, and cookies
Ehud Barak's Company Among Bidders for Israeli Cannabis Company Tikun Olam
15.09.19
|
Tzally Greenberg
Tikun Olam founder Tzahi Cohen has decided to sell the company’s Israeli business in August after an Israeli court ruled that he must reduce his stake to under 5% before the company’s growing license could be reinstated
Can-Fite’s Private Placement Could be Key to Avoiding a Hostile Takeover
11.09.19
|
Tzally Greenberg
NYSE and Tel Aviv-listed Israeli pharmaceutical company Can-Fite announced on Tuesday a collaboration agreement with Tel Aviv-listed medical cannabis cannabis company Univo, which will receive a 16.6% stake in the former
Controlled Drug Release Company Polypid Raises $50 Million
05.09.19
|
CTech
In March, clinical-stage Polypid backed out of its planned Nasdaq IPO
Previous Articles
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility